Safety of zoster vaccine in adults from a large managed‐care cohort: a Vaccine Safety Datalink study
Hung Fu Tseng(Kaiser Permanente), James Baggs, Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Lina S. Sy(Kaiser Permanente), Steven J. Jacobsen(Mayo Clinic), Sheila Weinmann(Kaiser Permanente), Bruce Fireman(Kaiser Permanente), A. Liu(Kaiser Permanente), James D. Nordin(HealthPartners), Eric Weintraub, S. Michael Marcy(Kaiser Foundation Hospital), Matthew F. Daley(Kaiser Permanente), Roger Baxter(Unknown)
Cited by 74
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
|Preventing Chronic Disease|2021|370